Early plasma biomarker dynamic profiles are associated with acute ischemic stroke outcomes
Manuel Correia, Luı́s F. Maia(Universidade do Porto), Rui Magalhães(Universidade do Porto), Joel Simrén(University of Gothenburg), Ricardo Varela(Albert Einstein College of Medicine), Karolina Minta(University College London), Ângelo Carneiro(Centro Hospitalar do Porto), Pedro Castro(Hospital de São João), Rui Antunes(University of Aveiro), Sara Ribeiro(Universidade do Porto), Denis Gabriel(RCA (United States)), Henrik Zetterberg(University of Wisconsin–Madison), Rui Felgueiras(Délégation Paris 5), Ana Aires(Universidade do Porto), Isabel Silva(Universidade do Porto), Hugo Mota Dória(Centro Hospitalar do Porto), Kaj Blenow(Sahlgrenska University Hospital)
Cited by 32
Related Papers
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
|JAMA Neurology|2021|627
Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report
|Nature Medicine|2019|606
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease
|Alzheimer s & Dementia|2022|589